Institution · Innate Pharma (France)
Most cited papers from Innate Pharma (France)
What are the most cited papers from Innate Pharma (France)?
The most cited paper from Innate Pharma (France) is "Innate Lymphoid Cells: 10 Years On" (Eric D. Vivier, David Artis, Marco Colonna et al., 2018), with 2,174 citations. Next come "Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells" (1,233) and "Human NK Cell Education by Inhibitory Receptors for MHC Class I" (1,182).
Showing 50 of 60 papers. Every paper with more than 162 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Innate Lymphoid Cells: 10 Years On Eric D. Vivier, David Artis, Marco Colonna et al. · Cell | Aug 2018 | 2,174 |
| 2 | Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells Pascale André et al. · Cell | 29 Nov 2018 | 1,233 |
| 3 | Human NK Cell Education by Inhibitory Receptors for MHC Class I Nicolas Anfossi, Pascale André, Sophie Guia et al. · Immunity | Aug 2006 | 1,182 |
| 4 | Natural killer cells and other innate lymphoid cells in cancer Laura Chiossone, Pierre‐Yves Dumas, Margaux Vienne et al. · Nature reviews. Immunology | 12 Sep 2018 | 1,040 |
| 5 | Single-cell immune landscape of human atherosclerotic plaques Dawn M. Fernandez et al. · Nature Medicine | Oct 2019 | 1,014 |
| 6 | Harnessing innate immunity in cancer therapy Olivier Demaria, Stéphanie Cornen, Marc Daëron et al. · Nature | 2 Oct 2019 | 963 |
| 7 | Natural selection on EPAS1 ( HIF2α ) associated with low hemoglobin concentration in Tibetan highlanders Cynthia M. Beall et al. · Proceedings of the National Academy of Sciences | 7 Jun 2010 | 858 |
| 8 | Maturation of mouse NK cells is a 4-stage developmental program Laura Chiossone, Julie Chaix, Nicolas Fuséri et al. · Blood | 21 Feb 2009 | 796 |
| 9 | Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity Émilie Mamessier, Aude Sylvain, Marie‐Laure Thibult et al. · Journal of Clinical Investigation | 15 Aug 2011 | 693 |
| 10 | Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis Julien Carvelli et al. · Nature | 29 Jul 2020 | 556 |
| 11 | Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans Pervinder Sagoo et al. · Journal of Clinical Investigation | 24 May 2010 | 521 |
| 12 | High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice Adeline Crinier, Pierre Milpied, Bertrand Escalière et al. · Immunity | Nov 2018 | 486 |
| 13 | Tumor-Infiltrating Natural Killer Cells Beatriz Cózar, Marco Greppi, Sabrina Carpentier et al. · Cancer Discovery | 4 Dec 2020 | 480 |
| 14 | Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46 Thierry Walzer, Mathieu Bléry, Julie Chaix et al. · Proceedings of the National Academy of Sciences | 21 Feb 2007 | 468 |
| 15 | Natural killer cell therapies Eric D. Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli et al. · Nature | 21 Feb 2024 | 466 |
| 16 | Predominant role for C5b-9 in renal ischemia/reperfusion injury Wuding Zhou, Conrad A. Farrar, Katsushige Abe et al. · Journal of Clinical Investigation | 15 May 2000 | 466 |
| 17 | Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity Laurent Gauthier et al. · Cell | 30 May 2019 | 437 |
| 18 | Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies Ivan Perrot et al. · Cell Reports | May 2019 | 430 |
| 19 | Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells François Romagné, Pascale André, Pieter Spee et al. · Blood | 25 Jun 2009 | 399 |
| 20 | NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines Nadine van Montfoort, Linda Borst, Michael J. Korrer et al. · Cell | 29 Nov 2018 | 338 |
| 21 | A Common Haplotype of the Dopamine Transporter Gene Associated With Attention-Deficit/Hyperactivity Disorder and Interacting With Maternal Use of Alcohol During Pregnancy Keeley J. Brookes, Jonathan S. Mill, Camilla Guindalini et al. · Archives of General Psychiatry | 2006 | 323 |
| 22 | Evidence of innate lymphoid cell redundancy in humans Frédéric Vely et al. · Nature Immunology | 12 Sep 2016 | 319 |
| 23 | A Spätzle-Processing Enzyme Required for Toll Signaling Activation in Drosophila Innate Immunity In-Hwan Jang, Naoyuki Chosa, Sunghee Kim et al. · Developmental Cell | 2006 | 318 |
| 24 | Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death Dan Weng, Robyn Marty-Roix, Sandhya Ganesan et al. · Proceedings of the National Academy of Sciences | 5 May 2014 | 311 |
| 25 | Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2 Lei Zhou, Coco Chu, Fei Teng et al. · Nature | Apr 2019 | 299 |
| 26 | Monalizumab: inhibiting the novel immune checkpoint NKG2A Thorbald van Hall, Pascale André, Amir Horowitz et al. · Journal for ImmunoTherapy of Cancer | 17 Oct 2019 | 297 |
| 27 | Transglutaminase-Based Chemo-Enzymatic Conjugation Approach Yields Homogeneous Antibody–Drug Conjugates Patrick Dennler, Aristeidis Chiotellis, Eliane Fischer et al. · Bioconjugate Chemistry | 3 Feb 2014 | 291 |
| 28 | Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties Jennifer Debarry, Holger Garn, Anna Hanuszkiewicz et al. · Journal of Allergy and Clinical Immunology | 4 May 2007 | 284 |
| 29 | Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides Sandra S. Diebold, Catherine Massacrier, Shizuo Akira et al. · European Journal of Immunology | 17 Nov 2006 | 284 |
| 30 | Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies Holbrook E K Kohrt, Ariane Thielens, Aurélien Marabelle et al. · Blood | 10 Dec 2013 | 279 |
| 31 | Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment Tristan Courau, Julie Bonnereau, Justine Chicoteau et al. · Journal for ImmunoTherapy of Cancer | 14 Mar 2019 | 273 |
| 32 | A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission Norbert Vey, Jean Bourhis, Nicolas Boissel et al. · Blood | 23 Sep 2012 | 273 |
| 33 | Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice Julia Yuen-Shan Tsang, Yakup Tanriver, Shuiping Jiang et al. · Journal of Clinical Investigation | 9 Oct 2008 | 269 |
| 34 | High-dimensional single-cell analysis of human natural killer cell heterogeneity Lucas Rebuffet et al. · Nature Immunology | 2 Jul 2024 | 265 |
| 35 | Host tissue determinants of tumour immunity Hélène Salmon, Romain Remark, Sacha Gnjatic et al. · Nature reviews. Cancer | 12 Mar 2019 | 255 |
| 36 | Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma Jaafar Bennouna, Emmanuelle Bompas, Eve Marie Neidhardt et al. · Cancer Immunology Immunotherapy | 26 Feb 2008 | 245 |
| 37 | Targeting natural killer cells in solid tumors Guillaume Habif, Adeline Crinier, Pascale André et al. · Cellular and Molecular Immunology | 25 Mar 2019 | 243 |
| 38 | A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma Don M. Benson, Craig C. Hofmeister, Swaminathan Padmanabhan et al. · Blood | 2 Oct 2012 | 242 |
| 39 | SnapShot: Natural Killer Cells Adeline Crinier, Émilie Narni-Mancinelli, Sophie Ugolini et al. · Cell | Mar 2020 | 241 |
| 40 | Functional IRF3 deficiency in a patient with herpes simplex encephalitis Line Lykke Andersen, Nanna Mørk, Line Sinnathamby Reinert et al. · The Journal of Experimental Medicine | 27 Jul 2015 | 236 |
| 41 | PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1 Marguerite Ghiotto, Laurent Gauthier, N-E Serriari et al. · International Immunology | 29 Jun 2010 | 232 |
| 42 | Overcoming innate immune barriers that impede AAV gene therapy vectors Manish Muhuri, Maeda Yukiko, Hong Ma et al. · Journal of Clinical Investigation | 3 Jan 2021 | 220 |
| 43 | NK cell MHC class I specific receptors (KIR): from biology to clinical intervention Ariane Thielens, Eric D. Vivier, François Romagné · Current Opinion in Immunology | 21 Jan 2012 | 208 |
| 44 | Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants Robyn Marty-Roix, Gregory Ian Vladimer, Kimberly Pouliot et al. · Journal of Biological Chemistry | 11 Nov 2015 | 205 |
| 45 | IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect Don M. Benson, Courtney E. Bakan, Shuhong Zhang et al. · Blood | 27 Oct 2011 | 203 |
| 46 | Novel Subset of CD8α+ Dendritic Cells Localized in the Marginal Zone Is Responsible for Tolerance to Cell-Associated Antigens Chun‐Hong Qiu, Yasunobu Miyake, Hitomi Kaise et al. · The Journal of Immunology | 19 Mar 2009 | 199 |
| 47 | New immune cell engagers for cancer immunotherapy Aurore Fenis, Olivier Demaria, Laurent Gauthier et al. · Nature reviews. Immunology | 25 Jan 2024 | 198 |
| 48 | Common Mechanistic Pathways in Cancer and Heart Failure. A Scientific Roadmap on Behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Rudolf A. de Boer et al. · European Journal of Heart Failure | 22 Oct 2020 | 189 |
| 49 | In Vivo Immunomanipulation of Vγ9Vδ2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model Hélène Sicard, Sophie Ingoure, Béatrice Luciani et al. · The Journal of Immunology | Oct 2005 | 188 |
| 50 | Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury Wilhelm Schwaeble, Nicholas J. Lynch, James Clark et al. · Proceedings of the National Academy of Sciences | 18 Apr 2011 | 188 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.